CW February 2000
Volume 9Issue Number 2 February 2000 ISSN 10593802 Docetaxel, Doxorubicin Combination in Advanced Breast Cancer TreatmentWeekly administration of docetaxel in combination with doxorubicin is a well-tolerated and effective regimen for the treatment of advanced breast cancer, according to preliminary results of a phase II trial presented at the 10th International Congress on Anti-Cancer Treatment (ICACT) in Paris, France, on Jan. 31 ? Feb. 3, 2000.
Go to Previous Page Go to Next Page Source & Additional Reading 10th International Congress on Anti-Cancer Treatment (ICACT) in Paris, France, on Jan. 31-Feb. 3, 2000. Purchase Downloadable Full-text PDF of Article: $10.00 Subscription is more cost effective than purchasing PDFs on-the-fly. Click here for details. Download Complete Issue CW February 2000Purchase Downloadable Full-text PDF of Complete Issue: $20.00 |
|
Member Login | Home | Offices | Subscribe | Glossary | Cancer Technologies | Contact Us
Adenine Press, 2066 Central Avenue, Schenectady, NY 12304 USA |
Re-initialize IP-based Login |
